These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 10393383

  • 1. Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
    Teruel JL, Tenorio MT, Rodríguez JR, Marc n R, Orofino L, Rivera M, Ortuño J.
    Am J Nephrol; 1999; 19(3):428-32. PubMed ID: 10393383
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 4. Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
    Perez-Mijares R, Gomez-Fernandez P, Almaraz-Jimenez M, Ramos-Diaz M, Rivero-Bohorquez J.
    Am J Nephrol; 1993 Feb; 13(2):149-54. PubMed ID: 8342582
    [Abstract] [Full Text] [Related]

  • 5. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Durham Renal Osteodystrophy Study Group.
    Indridason OS, Quarles LD.
    Kidney Int; 2000 Jan; 57(1):282-92. PubMed ID: 10620210
    [Abstract] [Full Text] [Related]

  • 6. Effect of administering calcium carbonate to treat secondary hyperparathyroidism in nondialyzed patients with chronic renal failure.
    Tsukamoto Y, Moriya R, Nagaba Y, Morishita T, Izumida I, Okubo M.
    Am J Kidney Dis; 1995 Jun; 25(6):879-86. PubMed ID: 7771484
    [Abstract] [Full Text] [Related]

  • 7. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ, van der Kuy A, ter Wee PM, van Boven WP.
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.
    Nephron; 1996 Feb; 74(1):89-103. PubMed ID: 8883025
    [Abstract] [Full Text] [Related]

  • 9. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 10. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL, Nitvarro JF, Marcen R, Aguilera A, Tato A, Ottuño J.
    Miner Electrolyte Metab; 1997 Dec; 23(1):19-24. PubMed ID: 9058365
    [Abstract] [Full Text] [Related]

  • 11. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA, Grenda R, Qiu P, Restaino I, Wojtak A, Paredes A, Benador N, Melnick JZ, Williams LA, Salusky IB.
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [Abstract] [Full Text] [Related]

  • 12. A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
    Chertow GM, Dillon M, Burke SK, Steg M, Bleyer AJ, Garrett BN, Domoto DT, Wilkes BM, Wombolt DG, Slatopolsky E.
    Clin Nephrol; 1999 Jan; 51(1):18-26. PubMed ID: 9988142
    [Abstract] [Full Text] [Related]

  • 13. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jan; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of secondary hyperparathyroidism in hemodialysis patients with oral pulse 1-alpha-hydroxy-cholecalciferol therapy.
    Rapoport J, Mostoslavski M, Ben-David A, Knecht A, Blau A, Arad J, Zlotnik M, Chaimovitz C.
    Nephron; 1996 Jan; 72(2):150-4. PubMed ID: 8684518
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
    Morinière P, Fournier A, Leflon A, Hervé M, Sebert JL, Grégoire I, Bataille P, Guéris J.
    Nephron; 1985 Jan; 39(4):309-15. PubMed ID: 3982576
    [Abstract] [Full Text] [Related]

  • 16. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Jan; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 17. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA, Tian J, Abboud H, Hippensteel R, Melnick JZ, Pradhan RS, Williams LA, Hamm LL, Sprague SM.
    Am J Nephrol; 2008 Jan; 28(1):97-106. PubMed ID: 17914251
    [Abstract] [Full Text] [Related]

  • 18. Secondary hyperparathyroidism in severe chronic renal failure is corrected by very-low dietary phosphate intake and calcium carbonate supplementation.
    Barsotti G, Cupisti A, Morelli E, Meola M, Cozza V, Barsotti M, Giovannetti S.
    Nephron; 1998 Jan; 79(2):137-41. PubMed ID: 9647491
    [Abstract] [Full Text] [Related]

  • 19. [The clinical evaluation of maxacalcitol on therapy for secondary hyperparathyroidism of chronic hemodialysis patients].
    Kasai K, Abe R, Wakabayashi M, Nakamura K, Sawatani S, Wakabayashi T.
    Nihon Jinzo Gakkai Shi; 2002 Jan; 44(5):464-70. PubMed ID: 12216479
    [Abstract] [Full Text] [Related]

  • 20. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H, Bayani M, Mohammadi M, Bayani B, Mashhadi MA.
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.